The respiratory activity in newborn preterm (29 days gestation) rabbits was studied after administration of thyrotropic releasing hormone. Intraperitoneal injection induced an increase in respiratory frequency (f) and a decrease in tidal volume (VT) resulting in a slight increase in pulmonary ventilation (VE). These effects were seen in parallel to a decrease in expiratory time (TE) and respiratory time (TToT). An increase in the TI/TTOT ratio but (unaffected) VT/TI ratio indicates that thyrotropic releasing hormone affects "respiratory timing" mechanisms rather than "inspiratory drive." The changes in respiratory parameters are most probably due to an effect on the central respiratory controlling centers in the brain stem.
Summary
The respiratory activity in newborn preterm (29 days gestation) rabbits was studied after administration of thyrotropic releasing hormone. Intraperitoneal injection induced an increase in respiratory frequency (f) and a decrease in tidal volume (VT) resulting in a slight increase in pulmonary ventilation (VE). These effects were seen in parallel to a decrease in expiratory time (TE) and respiratory time (TToT). An increase in the TI/TTOT ratio but (unaffected) VT/TI ratio indicates that thyrotropic releasing hormone affects "respiratory timing" mechanisms rather than "inspiratory drive." The changes in respiratory parameters are most probably due to an effect on the central respiratory controlling centers in the brain stem.
After an initial adaptation period in the couveuse of at least 1 h, the rabbit neonates were lightly anaesthetized with ether to permit cannulation of the trachea (Venflon cannula, Viggo AB, Sweden) and the peritoneal cavity (PP50, polyethylene, Portex Ltd, England). After the operative procedures and recovery from the ether Speculation The increased respiratory activity seen after administration of thyrotropic releasing hormone indicates that this tripeptide may have favourable effects in conditions accompanied by irregular or apnoic breathing during the perinatal period.
The basic rhythmic generator which controls respiratory frequency is located in the lower brain stem region (1). Traditionally, the major part of the work on central respiratory regulation has emphasized the location, connections and electrical properties of the cell groups in the lower part of the brain whose activity is altered in relation to the respiratory cycle. Little attention has previously been focused on the neurochemical mechanisms that are relevant to central respiratory control. However, such studies could provide a basis for the understanding and perhaps also the therapy of various disorders related to respiratory regulation. One such area could be neonatal irregular or apnoic breathing, where respiratory neuronal activity may malfunction due to immaturity or an imbalance between the development of respiratory stirnulating and depressive neuronal systems.
Recently, we have demonstrated that various systems such as monoaminergic (18, 19) , gabaergic (9, 10) and various peptidergic (1 1, 12, 13) neurons are involved in the regulation of central respiratory activity in adult and newborn animals. In these studies, we have found that intracerebroventricular administration of thyrotropic releasing hormone (TRH) markedly stimulated respiratory frequency in adult rats (1 1). This finding prompted us to further investigate the effects of systemic administration of TRH to preterm newborn rabbits.
MATERIALS AND METHODS
Preterm rabbits of Danish rural breed, weighing approximately 45 g, were used in the experiments. The rabbit fetuses were delivered at 29 days of gestation (term being 31 days) by cesarian section under general ether anaesthesia. After delivery the fetuses were immediately transferred to a couveuse (Aga MDOR-10, Sweden) and kept at 28-29°C until the initiation of the experiments. All experiments were performed within 6 h after birth. anaesthesia, the rabbit neonates were placed in a body plethysmograph (a glass fiber tube with internal diameter 8 cm and length 30 cm) with inlet and outlet holes at the ends for the tracheal tube, peritoneal catheter and volume recorder. The volume changes in the body plethysmograph were recorded with a 4 . Effects of TRH on inspiratory (TI), expiratory (TE) and respiratory (TTOT) time. TRH was given intraperitoneally, 5 mg/kg. Shown are means * S.E. of respiratory recordings from six preterm rabbit neonates.
* P < 0.05, **P < O.OI, ***P < 0.001. Fig. 3 . Effects of TRH on respiratory frequency (f), tidal volume (VT) and minute volume (vE). TRH was given intrapentoneally, 5 mg/kg. Shown are means f S.E. of respiratory recordings from six preterm rabbit neonates. * P < 0.05, **P < 0.01, and ***P < 0.001.
drive" and "respiratory timing," VT/TI and TI/TTOT, respectively, were calculated. Experiments were started after a minimum stabilization period in the body plethysmograph of 10 min. After the control recordings and a 10% C 0 2 challenge, TRH (Bachem Feinchem. AG) 0.5-10 mg/kg was injected via the intraperitoneal catheter. The respiratory variables were then followed for 15 min and a new 10% CO2 challenge was performed at the end of the experiment. In some animals saline was given in an equal volume (1 m1/100 g) in order to obtain control recordings for the whole experimental interval studied (Fig. 2) .
Statistics were carried out by a two way analysis of variance low pressure transducer (Grass Instrument Co, PT-5A) connected to a model 5 Grass polygraph. During the experiments the rabbit neonates were allowed to breathe 0.7% halothane in 100% 0 2 by means of a Draeger vaporizer. The internal temperature in the body plethysmograph was controlled and adjusted to 28-29OC. Tidal volume (VT) and respiratory frequency (f) were recorded before (controls) and after drug administration. Minute volume (VE) was calculated according to the formula VT X f = VE. Respiratory time (TToT), inspiratory time (TI) and expiratory time (TE) were calculated from the respiratory curve at low chart speed according to Figure 1 . In order to get an estimate for "inspiratory followed by t test or by paired t test. P values of 0.05 or less were considered significant. there was a marked increase in f accompanied by a slight decrease in VT (Fig. 2 and 3) . The increase in f occurred rapidly and was (Fig. 3) . The classical product of f and VT, the pulmonary ventilation (VE), was slightly increased after TRH injection (Fig.  3) . After 7 min, VE was approximately 50% increased compared to the preinjection value (16.24 + 2.28 versus 9.73 + 1.27;.n = 6; P < 0.05 paired t test). As for f and VT, the increase in VE was stable after 10 min of observation and forwards.
During the interval studied (15 min) there was no attenuation of the effects of TRH on f, VT or VE.
The respiratory time intervals all decreased in parallel to the increase in f. TE and TTOT were most markedly declined (Fig. 4) , generally to about half of its original values. On the contrary there was only a slighter decline in TI (Fig. 4) .
In the dose-response study performed, 0.5-10 mg/kg TRH was given. Both f and VE increased while VT decreased in a doserelated way (Fig. 5) . The respiratory time intervals, TI, TE and TTOT, decreased with increasing doses of TRH (Fig. 6) . The mean inspiratory flow (VT/TI) was calculated before and after TRH administration (Fig. 7) . This is a parameter related to inspiratory neural drive (7). After TRH, 5 mg/kg, there was no significant difference in VT/Tr compared to the control registration. The TI/TTOT ratio is a factor which indicates how "respiratory timing" affects the respiration (7) . A change in pulmonary ventilation can be due to a change in VT/TI or TI/TTOT as pulmonary ventilation is related to the mean inspjratory flow and "respiratory timing" according to the formula VE = (VT/TI) X (TI/TToT) (7). An increase in TI/TTOT thus implies that the duration of expiration has decreased disproportionately in relation to the duration of inspiration. This may be caused by central nervous or peripheral reflex influences (4, 6, 8 (Fig.  7) . In order to get a further evaluation of the central respiratory drive in the newborn rabbits we have analysed COZ induced changes on respiratory parameters. The COz sensing and responding mechanism is considered to be located in the reticular formation near the ventral surface of the medulla (1). The response to COz is also unaltered after denervation of the peripheral chemoreceptors (I). The addition of 10% COZ to the inhalational gas induced an increase in VT and VE during the control registration (Fig. 8 ). An almost equal but nonsignificant trend for VT and VE was seen after TRH.
DISCUSSION
Since the initial isolation of TRH from the hypothalamus (3, 21) it has become evident that this tripeptidke is distributed throughout the extrahypothalamic central nervous system (CNS) and spinal cord (2, 16, 24) .
In the pituitary, TRH has a role in the tonic release of thyroid stimulating hormone. However, the major control of thyroid stimulating hormone secretion appears to be through direct feedback by thyroid hormones at the pituitary level (23) . From immunohistochemical studies it can be estimated that only about one-third of the total CNS content of TRH may be found in the hypothalamus (2, 16, 24) . Also several lines of evidence suggest that extrahypothalamic regions possess the ability to synthesize TRH independent of any hypothalamic source (25) . Thus, with regard to the distribution and physiologic effect of TRH in the CNS, it seems to be more relevant to look at this peptide as a neurotransmitter that has been co-opted by the pituitary as a releasing factor.
Immunohistochemical studies have revealed a high density of TRH immunofluorescent cell bodies and nerve terminals in "autonomic areas" relevant to central respiratory control in the brain stem region (2, 16, 24) .
A high dose of parenterally administered TRH will cause a number of effects in experimental animals, which are similar to those seen after intracerebroventricular administration (25) .
We found that TRH administration to preterm neonatal rabbits caused a dose-dependent respiratory stimulation which was rapid in onset. The increase in minute volume was seen as a result of a marked increase in respiratory frequency. After TRH the total cycle duration (TTOT) was decreased. The shortening of TTOT was due to a marked decrease in TE, whereas TI was only slightly reduced. Indeed, the increase in minute volume was due to the changes in respiratory timing mechanisms as evidenced by the increase in the TI/TTOT "respiratory timing" ratio, mainly resulting from a relatively larger decrease in TTOT (or TE) compared to TI.
The slight reduction of VT, which was seen after TRH, was probably secondary to the slight reduction in TI. The "inspiratory drive," indicated by the mean inspiratory flow (VT/Tr) was not significantly changed after TRH. This also indicates that TRH increases ventilation chiefly as a result of its effect on respiratory timing, i. e., TI/TTOT.
The change in TI/TTOT is most probably due to central nervous mechanisms and not peripheral reflex influences, as adiministration of TRH by the intracerebroventricular route to the rat stimulates respiration in the same manner (11). In microinjection studies in cats, TRH induces respiratory stimulation when injected into mesencephalic structures (20) . Moreover, TRH also acts as a respiratory stimulant when administered to the primate (17) .
In the untreated animals, COz stimulated minute ventilation mainly by an increase in tidal volume. After TRH no significant alterations were seen after COz. It seems logical that TRH stimulates ventilation by mechanism unrelated to COz disposition. The mechanical changes after TRH, most likely causing a decrease in PaC02 would then tentatively explain the lack of effect of the COz challenge after TRH. However, this could only be fully clarified by measuring arterial COz tensions, which was not performed during the present study.
During prenatal or early postnatal life, the CNS of most mammals is relatively immature. Thus many neuronal systems which are involved in central respiratory regulation such as catecholaminergic (IS), serotoninergic, (14) , gabaergic (5), and various peptidergic (22) systems may exhibit various degrees of maturity. Thus the net effect of respiratory "maturity" will depend on the relative balance between the maturation of respiratory stimulating and depressive systems. During a certain period of early postnatal age there may be a predominance of respiratory depressive input, which may serve as a base for irregular breathing and apnoic spells seen in the neonate. However, by identifying natural transmitters or transmitter analogues which act as respiratory stimulants, this balance may be changed. TRH seems to act in this way by stimulating respiratory activity also after intraperitoneal administration. Moreover, TRH acts neurotropic after intravenous, subcutaneous and oral administration (25) . The rapid onset of action and relatively long duration (25) may further warrant the testing of TRH as a respiratory stimulant during the perinatal period.
